Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography

[1] Moffat GT(2019)Pancreatic cancer-a disease in need: optimizing and integrating supportive care Cancer. 125 3927-3935

[2] Epstein AS(2019)Differentiation of autoimmune pancreatitis from pancreatic Cancer remains challenging World J Surg 43 1604-1611

[3] O'Reilly EM(2014)Autoimmune pancreatitis: a surgical dilemma Cir Esp 92 645-653

[4] Dickerson LD(2020)Autoimmune pancreatitis: an update Abdom Radiol 45 1359-1370

[5] Farooq A(2017)Potential biomarkers in Lewis negative patients with pancreatic cancer Ann Surg 265 800-805

[6] Bano F(2012)The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal J Gastrointest Oncol 3 105-119

[7] Saavedra-Perez D(2017)Type 2 autoimmune pancreatitis: a challenge in the differential diagnosis of a pancreatic mass GE Port J Gastroenterol 24 296-300

[8] Vaquero EC(2015)Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis Pancreas 44 557-560

[9] Ayuso JR(2007)Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer Am J Gastroenterol 102 1646-1653

[10] Khandelwal A(2014)Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography J Comput Assist Tomogr 38 146-152

[1] Moffat GT(2019)Pancreatic cancer-a disease in need: optimizing and integrating supportive care Cancer. 125 3927-3935

[2] Epstein AS(2019)Differentiation of autoimmune pancreatitis from pancreatic Cancer remains challenging World J Surg 43 1604-1611

[3] O'Reilly EM(2014)Autoimmune pancreatitis: a surgical dilemma Cir Esp 92 645-653

[4] Dickerson LD(2020)Autoimmune pancreatitis: an update Abdom Radiol 45 1359-1370

[5] Farooq A(2017)Potential biomarkers in Lewis negative patients with pancreatic cancer Ann Surg 265 800-805

[6] Bano F(2012)The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal J Gastrointest Oncol 3 105-119

[7] Saavedra-Perez D(2017)Type 2 autoimmune pancreatitis: a challenge in the differential diagnosis of a pancreatic mass GE Port J Gastroenterol 24 296-300

[8] Vaquero EC(2015)Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis Pancreas 44 557-560

[9] Ayuso JR(2007)Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer Am J Gastroenterol 102 1646-1653

[10] Khandelwal A(2014)Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography J Comput Assist Tomogr 38 146-152